Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients.
Front Oncol. 2023 May 29;13:1182725. doi: 10.3389/fonc.2023.1182725. eCollection 2023.
Front Oncol. 2023.
PMID: 37313470
Free PMC article.
Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes.
de la Morena Barrio P, Conesa MÁ, González-Billalabeitia E, Urrego E, García-Garre E, García-Martínez E, Poves MZ, Vicente V, de la Peña FA.
de la Morena Barrio P, et al.
J Natl Compr Canc Netw. 2015 Apr;13(4):417-23. doi: 10.6004/jnccn.2015.0057.
J Natl Compr Canc Netw. 2015.
PMID: 25870378
Item in Clipboard
A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge.
Vicente Conesa MA, Zafra Poves M, Carmona-Bayonas A, Ballester Navarro I, de la Morena Barrio P, Ivars Rubio A, Montenegro Luis S, García Garre E, Vicente V, Ayala de la Peña F.
Vicente Conesa MA, et al. Among authors: de la morena barrio p.
ESMO Open. 2022 Feb;7(1):100384. doi: 10.1016/j.esmoop.2022.100384. Epub 2022 Feb 7.
ESMO Open. 2022.
PMID: 35144121
Free PMC article.
Item in Clipboard
Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer.
García-Torralba E, Pérez Ramos M, Ivars Rubio A, Navarro-Manzano E, Blaya Boluda N, de la Morena Barrio P, García-Garre E, Martínez Díaz F, Chaves-Benito A, García-Martínez E, Ayala de la Peña F.
García-Torralba E, et al. Among authors: de la morena barrio p.
Cancers (Basel). 2023 May 20;15(10):2846. doi: 10.3390/cancers15102846.
Cancers (Basel). 2023.
PMID: 37345183
Free PMC article.
Item in Clipboard
Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).
Antolín Novoa S, Escrivá-de-Romaní S, Tolosa Ortega P, Oliva Fernández L, López López R, López González A, de la Morena Barrio P, Echavarria Díaz-Guardamino I, Alés Martinez JE, Garate Z, González-Cortijo L.
Antolín Novoa S, et al. Among authors: de la morena barrio p.
Cancer Treat Res Commun. 2023;37:100772. doi: 10.1016/j.ctarc.2023.100772. Epub 2023 Nov 1.
Cancer Treat Res Commun. 2023.
PMID: 37995519
Free article.
Item in Clipboard
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes.
Garcia-Torralba E, Pérez Ramos M, Ivars Rubio A, Navarro Manzano E, Blaya Boluda N, Lloret Gil M, Aller A, de la Morena Barrio P, García Garre E, Martínez Díaz F, García Molina F, Chaves Benito A, García-Martínez E, Ayala de la Peña F.
Garcia-Torralba E, et al. Among authors: de la morena barrio p.
Breast Cancer Res Treat. 2024 Jun;205(3):475-485. doi: 10.1007/s10549-024-07286-x. Epub 2024 Mar 7.
Breast Cancer Res Treat. 2024.
PMID: 38453782
Free PMC article.
Item in Clipboard
Cite
Cite